Effect of acute administration of hydroalcohol extract of Ilex paraguariensis St Hilaire (Aquifoliaceae) in animal models of Parkinson's disease
暂无分享,去创建一个
E M Milioli | P Cologni | C C Santos | T D Marcos | V M Yunes | M S Fernandes | T Schoenfelder | L Costa-Campos | L. Costa-Campos | C. Santos | T. Schoenfelder | M. S. Fernandes | T. Marcos | C. C. Santos | E. M. Milioli | P. Cologni | T. D. Marcos | V. M. Yunes | E. Milioli | V. Yunes
[1] B. Halliwell,et al. Formation of a thiobarbituric‐acid‐reactive substance from deoxyribose in the presence of iron salts , 1981 .
[2] P. Jenner,et al. Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease. , 1997, Trends in pharmacological sciences.
[3] P. Svenningsson,et al. Distribution, biochemistry and function of striatal adenosine A2A receptors , 1999, Progress in Neurobiology.
[4] R. Lamuela-Raventós,et al. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent , 1999 .
[5] A. Gugliucci,et al. Ilex paraguariensis extracts are potent inhibitors of nitrosative stress: a comparative study with green tea and wines using a protein nitration model and mammalian cell cytotoxicity. , 2005, Life sciences.
[6] G. Schinella,et al. Antioxidant effects of an aqueous extract of Ilex paraguariensis. , 2000, Biochemical and biophysical research communications.
[7] J. Trojanowski,et al. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. , 2002, Free radical biology & medicine.
[8] M. Schwarzschild,et al. Neuroprotection by Caffeine and A2A Adenosine Receptor Inactivation in a Model of Parkinson's Disease , 2001, The Journal of Neuroscience.
[9] E. Wang,et al. Modelling the effects of age-related mtDNA mutation accumulation; complex I deficiency, superoxide and cell death. , 1995, Biochimica et biophysica acta.
[10] C. Tanner,et al. Association of coffee and caffeine intake with the risk of Parkinson disease. , 2000, JAMA.
[11] Nizam Uddin Khan,et al. Antioxidant and prooxidant properties of caffeine, theobromine and xanthine. , 2003, Medical science monitor : international medical journal of experimental and clinical research.
[12] D. Perl,et al. Protein Nitration in Parkinson's Disease , 1998, Journal of neuropathology and experimental neurology.
[13] J. Xie,et al. Parkinson's Disease Brain Mitochondrial Complex I Has Oxidatively Damaged Subunits and Is Functionally Impaired and Misassembled , 2006, The Journal of Neuroscience.
[14] Anthony H V Schapira,et al. Etiology of Parkinson’s disease , 2006, Neurology.
[15] Z. Deng,et al. Separation procedures for naturally occurring antioxidant phytochemicals. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[16] Koji Yamada,et al. Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP , 1999, Psychopharmacology.
[17] P. López,et al. Phenolic compounds in seven South American Ilex species. , 2001, Fitoterapia.
[18] B. Ferger,et al. Neuroprotective effects of (±)‐kavain in the MPTP mouse model of Parkinson's disease , 2001, Synapse.
[19] S. G. Leitão,et al. Screening of Brazilian plant extracts for antioxidant activity by the use of DPPH free radical method , 2001, Phytotherapy research : PTR.
[20] M. Erion,et al. The therapeutic potential of agents acting via purine receptors. , 1998, Expert opinion on investigational drugs.
[21] P. Jenner,et al. A2A antagonists as novel non-dopaminergic therapy for motor dysfunction in PD , 2003, Neurology.
[22] A. Gugliucci,et al. Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea. , 2005, Fitoterapia.
[23] C. Olanow,et al. The pathogenesis of cell death in Parkinson's disease , 2006, Neurology.
[24] B. Bartholomew. A rapid method for the assay of nitrate in urine using the nitrate reductase enzyme of Escherichia coli. , 1984, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[25] E. Vaudano,et al. KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse , 2005, Neuropharmacology.
[26] M. Caporali,et al. Akinesia due to catecholamine depletion in mice is prevented by caffeine. Further evidence for an involvement of adenosinergic system in the control of motility , 1991, The Journal of pharmacy and pharmacology.
[27] E. Oztaş,et al. Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson’s disease , 2003, Neurology.
[28] P. Mazzafera. Maté drinking: caffeine and phenolic acid intake , 1997 .
[29] P. Riederer,et al. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man , 2005, Journal of Neural Transmission.
[30] Richard J Smeyne,et al. The MPTP model of Parkinson's disease. , 2005, Brain research. Molecular brain research.